About Xlumena
Xlumena is a company based in Mountain View (United States) founded in 2008 was acquired by Boston Scientific in April 2015.. Xlumena has raised $73.68 million across 7 funding rounds from investors including Boston Scientific, Western Technology Investment and Ascent Biomedical Ventures. The company has 2 employees as of December 31, 2017. Xlumena operates in a competitive market with competitors including Sequana Medical, Yaqrit, Salient Surgical Technologies, CalmiGo and Autem Therapeutics, among others.
- Headquarter Mountain View, United States
- Employees 2 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Xlumena
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$73.68 M (USD)
in 7 rounds
-
Latest Funding Round
$25 M (USD), Series C
Dec 03, 2014
-
Investors
Boston Scientific
& 7 more
-
Employee Count
2
as on Dec 31, 2017
-
Acquired by
Boston Scientific
(Apr 01, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Xlumena
Xlumena has successfully raised a total of $73.68M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in December 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $25.0M
-
First Round
First Round
(01 May 2008)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2014 | Amount | Series C - Xlumena | Valuation | Third Point | |
| Feb, 2014 | Amount | Series C - Xlumena | Valuation |
investors |
|
| Oct, 2013 | Amount | Series B - Xlumena | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Xlumena
Xlumena has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Western Technology Investment and Ascent Biomedical Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
A healthcare-focused investment firm supporting innovative company growth.
|
Founded Year | Domain | Location | |
|
VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Xlumena
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Xlumena
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Xlumena Comparisons
Competitors of Xlumena
Xlumena operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, Yaqrit, Salient Surgical Technologies, CalmiGo and Autem Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| domain | founded_year | HQ Location |
Liver dialysis devices for treating cirrhosis and failure are developed.
|
|
| domain | founded_year | HQ Location |
Electrosurgical systems for surgical resections and procedures are developed.
|
|
| domain | founded_year | HQ Location |
Stress-relief devices are developed using smart breathing regulation technology.
|
|
| domain | founded_year | HQ Location |
Bioelectric platforms for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Xlumena
When was Xlumena founded?
Xlumena was founded in 2008.
Where is Xlumena located?
Xlumena is headquartered in Mountain View, United States. It is registered at Mountain View, California, United States.
Is Xlumena a funded company?
Xlumena is a funded company, having raised a total of $73.68M across 7 funding rounds to date. The company's 1st funding round was a Series B of $6M, raised on May 01, 2008.
How many employees does Xlumena have?
As of Dec 31, 2017, the latest employee count at Xlumena is 2.
What does Xlumena do?
Xlumena develops image-guided therapeutic endoscopy products. It develops Bile Duct Stenting, a self-expanding anchor stent and precision XL delivery system; Translumenal Access for Translumenal delivery of endoscopic instruments and devices using the integrated Exchange Free (XF) delivery system; Gallbladder Drainage that drains the gallbladder into the duodenum or stomach using a lumenal approximating stent and precision delivery system; and Bile and Pancreatic Duct Drainage, which creates an anastomotic bypass to drain the bile ducts or pancreatic ducts into the duodenum using the integrated XF delivery system, lumenal approximation tools, and novel anchor stent. The company also develops Pseudocyst Drainage, an integrated XF system designed to enable reliable pseudocyst drainage; and Hiatal Hernia Repair that enables the repair of a hiatal hernia from inside the GI lumen.
Who are the top competitors of Xlumena?
Xlumena's top competitors include Sequana Medical, Yaqrit and CalmiGo.
Who are Xlumena's investors?
Xlumena has 8 investors. Key investors include Boston Scientific, Western Technology Investment, Ascent Biomedical Ventures, Aperture Venture Partners, and Prism Venture Partners.